Gland Pharma Ltd - 543245 - Closure of Trading Window
Intimation regarding Trading Window Closure of Gland Pharma Limited28-06-2024
28-06-2024
Gland Pharma Ltd - 543245 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mirae Asset Mutual Fund26-06-2024
Gland Pharma Ltd - 543245 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Fosun Pharma Industrial Pte Ltd24-06-2024
Gland Pharma promoter Fosun divests 6% stake for Rs 1,754 cr via bulk deal
Fosun Pharma, one of the promoters of Gland Pharma, on Wednesday divested a 6 per cent stake for Rs 1,754 crore through an open market transaction. Chinese drug firm Fosun Pharma, through its arm Fosun Pharma Industrial Pte, offloaded the shares of Hyderabad-based Gland Pharma through a bulk deal on the BSE. According to the bulk deal data available on the BSE, Fosun Pharma Industrial Pte disposed of 99 lakh shares or a 6 per cent stake in Gland Pharma. The shares were sold at an average price of Rs 1,771.81 apiece, taking the deal size to Rs 1,754.09 crore. After the stake sale, Fosun Pharma's shareholding in Gland Pharma has declined to 51.86 per cent from 57.86 per cent. Meanwhile, UBS Principal Capital Asia picked up 8.25 lakh shares, amounting to a 0.5 per cent stake in Gland Pharma. The shares were purchased at an average price of Rs 1,771.05 per piece, taking the transaction value to Rs 146.11 crore. Details of the other buyers of Gland Pharma's shares could not be...19-06-2024
Gland Pharma appoints incumbent MD & CEO Srinivas Sadu as Executive Chairman & CEO
Srinivas Sadu's career with Gland Pharma began in 2000; he will assume his new role on June 10, 202408-06-2024
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of 41,200 equity shares under ESOP07-06-2024
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Srinivas Sadu appointed as Executive Chairman and CEO of Gland Pharma Limited07-06-2024
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Change in Directorate
Completion of tenure of Mr. Yiu Kwan Stanley Lau, Chairman and Independent Director07-06-2024
Gland Pharma Ltd - 543245 - Board Meeting Outcome for Outcome Of The Board Meeting Held On June 07, 2024
Outcome of the Board Meeting held on June 07, 202407-06-2024
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation regarding Schedule of Analyst/Investor Meet on June 10, 202407-06-2024